CliffBio
small molecule

HYDROCORTISONE SODIUM SUCCINATE

HYDROCORTISONE SODIUM SUCCINATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCORTISONE SODIUM SUCCINATE
Active ingredientHYDROCORTISONE SODIUM SUCCINATE
StrengthEQ 100MG BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalFebruary 2026
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.